Abstract
Glioblastoma is the most aggressive tumor of the central nervous system, due to its great infiltration capacity. Understanding the mechanisms that regulate the Glioblastoma invasion front is a major challenge with preeminent potential clinical relevances. In the infiltration front, the key features of tumor dynamics relate to biochemical and biomechanical aspects, which result in the extension of cellular protrusions known as tumor microtubes. The coordination of metalloproteases expression, extracellular matrix degradation, and integrin activity emerges as a leading mechanism that facilitates Glioblastoma expansion and infiltration in uncontaminated brain regions. We propose a novel multidisciplinary approach, based on in vivo experiments in Drosophila and mathematical models, that describes the dynamics of active and inactive integrins in relation to matrix metalloprotease concentration and tumor density at the Glioblastoma invasion front. The mathematical model is based on a non-linear system of evolution equations in which the mechanisms leading chemotaxis, haptotaxis, and front dynamics compete with the movement induced by the saturated flux in porous media. This approach is able to capture the relative influences of the involved agents and reproduce the formation of patterns, which drive tumor front evolution. These patterns have the value of providing biomarker information that is related to the direction of the dynamical evolution of the front and based on static measures of proteins in several tumor samples. Furthermore, we consider in our model biomechanical elements, like the tissue porosity, as indicators of the healthy tissue resistance to tumor progression.
Highlights
Glioblastoma is the most common, aggressive, and lethal tumor of the central nervous system
Glioblastoma (GB) is a type of brain cancer that originated from glial cells
The infiltrative nature of GB cells is a key feature for understanding its aggressiveness and resistance to current treatments
Summary
Glioblastoma is the most common, aggressive, and lethal tumor of the central nervous system. It has a glial origin and it is characterized by rapid cell proliferation, great infiltration capacity, and neurological impairment [1]. GB is composed of a heterogeneous genetic landscape of tumor cells [2] that reduces the efficiency of clinical treatments. TMs mediate GB progression, and they interact with the synapses of the neighboring neurons [8, 9]. How do these fronts occur? Which are the mechanical and chemical processes that characterize these front areas of GB progression? Which are the main agents involved? What is the role of TMs in the tumor front development? Is there any heterogeneity in the spatial distribution of the tumor activity across the tumor domain?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.